Holen Sie sich die Stockscreener-App
1.00
0.76%
0.0075
Vorhandelsmarkt:
.98
-0.02
-2.00%
Schlusskurs vom Vortag:
$0.9925
Offen:
$0.99
24-Stunden-Volumen:
51,706
Relative Volume:
0.03
Marktkapitalisierung:
$24.20M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.43%
1M Leistung:
-2.91%
6M Leistung:
+28.39%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.979
$1.0098
1-Wochen-Bereich:
$0.951
$1.01
52-Wochen-Spanne:
$0.5555
$2.75
Metavia Inc Stock (MTVA) Company Profile
Firmenname
Metavia Inc
Sektor
Branche
Telefon
(857) 702-9600
Adresse
545 CONCORD AVENUE, CAMBRIDGE
Vergleichen Sie MTVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
1.00 | 24.02M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
Metavia Inc Aktie (MTVA) Neueste Nachrichten
Real time breakdown of MetaVia Inc. stock performance2025 Technical Overview & High Accuracy Trade Alerts - newser.com
What’s next for MetaVia Inc. stock price2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
MetaVia Inc. stock prediction for this weekJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
MetaVia Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Why MetaVia Inc. stock could outperform in 2025July 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
Is it too late to sell MetaVia Inc.Market Growth Review & Free AI Powered Buy and Sell Recommendations - newser.com
How to manage a losing position in MetaVia Inc.July 2025 Trends & AI Powered Trade Plan Recommendations - newser.com
Sector ETF performance correlation with MetaVia Inc.Trade Ideas & Daily Oversold Bounce Ideas - newser.com
How MetaVia Inc. stock reacts to bond yields2025 Trading Volume Trends & Real-Time Volume Spike Alerts - newser.com
Ranking MetaVia Inc. among high performing stocks via toolsJuly 2025 Catalysts & Low Risk Growth Stock Ideas - newser.com
How to build a dashboard for MetaVia Inc. stockTrade Entry Summary & Free Daily Entry Point Trade Alerts - newser.com
Metavia Inc. Advances Obesity Treatment with New Clinical Study - TipRanks
MetaVia Announces Poster Presentation on Vanoglipel (DA-1241) at the AASLD Liver Meeting - Lelezard
MetaVia (Nasdaq: MTVA) to present vanoglipel (DA-1241) MASH poster at AASLD Nov 10 - Stock Titan
Finanzdaten der Metavia Inc-Aktie (MTVA)
Es liegen keine Finanzdaten für Metavia Inc (MTVA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Metavia Inc-Aktie (MTVA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):